embecta | Sustainability Performance
Specializes in medical devices, particularly for diabetes care. Offers solutions to support the treatment and management of chronic conditions with a focus on reliability and patient outcomes.
1924
United States
1,001 - 5,000 employees
Medical Device
$1B - 10B in revenue
$25M - 100M in profitability
Sustainability Ranking & Industry Benchmark
#8544
Overall#1923
in United States#128
in Medical DeviceSustainability Maturity
Sustainability Intent
Overview
Environmental
Energy consumption
Renewable energy
Critical
Renewable electricity
Reveal data for 1 credit
15%2023
Industry rank: 9 out of 175
Total electricity consumption
and % renewables
(MWh, % of consumption)
Industry rank: 9 out of 175
Total electricity
Share of renewable electricity
Industry benchmark
Controversy level
- Embecta (BD diabetes spinoff) faces inherited product liability exposure from Becton Dickinson's legacy diabetes care portfolio including insulin pen safety class actions, plus sustained pricing scrutiny from US state Medicaid agencies over insulin pen needle pricing.
